Article Topic
FDA Alert: Class 1 Recall of Unauthorized Covid-19 Tests
This is a reprint of an FDA Alert. SD Biosensor Recalls STANDARD Q COVID-19 Ag Home Tests That Are Not Authorized, Cleared, or Approved by the FDA and May Give False Results The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious…
[...]March 16, 2022 Video: Dodgy Drug Websites & HIV
Many criminals are in the fake HIV drug business, and the drugs they sell online are a big threat to the health of HIV patients. Learn more here.
[...]March 9, 2022 Video: Narcotics for Sale
What’s more shocking than a fake online pharmacy selling fake medicines to desperate patients? The same sites selling illicit drugs like fentanyl. It’s one more reason to support the DRUGS Act.
[...]FDA Issues Warning About Unauthorized Covid-19 At-Home Tests
The U.S. Food and Drug Administration (FDA) is warning people not to use the SD Biosensor Inc. STANDARD Q COVID-19 Ag Home Test. The test is not authorized, cleared, or approved by the FDA for distribution or use in the United States. The FDA is concerned about the risk of false results when using this unauthorized test. This unauthorized test may be packaged in a white and magenta box.
[...]March 2, 2022 Video: Stop Notorious Websites
Learn how this year’s Notorious Markets Report illustrates need for the DRUGS Act.
[...]February 28, 2022: Study shows that suspending rogue pharmacy websites suppresses them in search results
LegitScript’s three-month study found that locking and suspending rogue online pharmacy websites suppressed them in search engine results.
Catch up on this and more than 30 other stories here.
[...]Connecticut Bioscience Growth Council ED explains why drug importation is “unworkable.”
In this February 24, 2022 editorial published on the Connecticut Business & Industry Association’s website, Paul Pescatello reviews the practical reasons that mean that importing drugs from Canada will not lower prescription drug prices. Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.
[...]A Fentanyl Fighting Blueprint: The Commission On Combating Synthetic Opioid Trafficking’s Final Report
The Commission on Combating Synthetic Opioid Trafficking’s Final Report makes recommendations for a complex, multipronged federal response to the fentanyl crisis.
[...]February 22, 2022: This year’s review of Notorious Markets for Counterfeiting and Piracy is out
The Office of the US Trade Representative released this year’s Review of Notorious Markets, which identifies markets that “engage in, facilitate, turn a blind eye to, or benefit from substantial piracy or counterfeiting.”
Click through to see this report, and catch up on more than 30 stories about counterfeit medicine.
[...]How can families affected by fentanyl or fake medicines become advocates in 2022?
Has your family been affected by fentanyl or fake pills? Learn about opportunities in 2022 to advocate to address the crisis in this webinar about federal legislation this year.
[...]